
### [NCIT:C4893](http://purl.obolibrary.org/obo/NCIT_C4893)
**Label:** Benign Urinary System Neoplasm

**Subclasses:** [NCIT:C3842](http://purl.obolibrary.org/obo/NCIT_C3842) (Urothelial Papilloma), [NCIT:C4778](http://purl.obolibrary.org/obo/NCIT_C4778) (Benign Kidney Neoplasm), [NCIT:C4532](http://purl.obolibrary.org/obo/NCIT_C4532) (Benign Accessory Urethral Gland Neoplasm), [NCIT:C7504](http://purl.obolibrary.org/obo/NCIT_C7504) (Cystic Nephroma), [NCIT:C27253](http://purl.obolibrary.org/obo/NCIT_C27253) (Metanephric Adenoma), [NCIT:C6178](http://purl.obolibrary.org/obo/NCIT_C6178) (Bladder Leiomyoma), [NCIT:C5100](http://purl.obolibrary.org/obo/NCIT_C5100) (Kidney Fibroma), [NCIT:C5101](http://purl.obolibrary.org/obo/NCIT_C5101) (Kidney Lipoma), [NCIT:C4530](http://purl.obolibrary.org/obo/NCIT_C4530) (Ureter Polyp), [NCIT:C6174](http://purl.obolibrary.org/obo/NCIT_C6174) (Ureter Inverted Papilloma), [NCIT:C6173](http://purl.obolibrary.org/obo/NCIT_C6173) (Urethral Inverted Papilloma), [NCIT:C6161](http://purl.obolibrary.org/obo/NCIT_C6161) (Ureter Leiomyoma), [NCIT:C6160](http://purl.obolibrary.org/obo/NCIT_C6160) (Ureter Urothelial Papilloma), [NCIT:C66774](http://purl.obolibrary.org/obo/NCIT_C66774) (Ossifying Renal Tumor of Infancy), [NCIT:C39859](http://purl.obolibrary.org/obo/NCIT_C39859) (Bladder Inverted Papilloma), [NCIT:C39858](http://purl.obolibrary.org/obo/NCIT_C39858) (Bladder Urothelial Papilloma), [NCIT:C39834](http://purl.obolibrary.org/obo/NCIT_C39834) (Bladder Squamous Papilloma), [NCIT:C39812](http://purl.obolibrary.org/obo/NCIT_C39812) (Metanephric Adenofibroma), [NCIT:C4526](http://purl.obolibrary.org/obo/NCIT_C4526) (Kidney Oncocytoma), [NCIT:C8960](http://purl.obolibrary.org/obo/NCIT_C8960) (Hereditary Kidney Oncocytoma), [NCIT:C6187](http://purl.obolibrary.org/obo/NCIT_C6187) (Renal Pelvis Inverted Papilloma), [NCIT:C6192](http://purl.obolibrary.org/obo/NCIT_C6192) (Inverted Urothelial Papilloma), [NCIT:C6171](http://purl.obolibrary.org/obo/NCIT_C6171) (Urethral Leiomyoma), [NCIT:C5061](http://purl.obolibrary.org/obo/NCIT_C5061) (Urethral Urothelial Papilloma), [NCIT:C37264](http://purl.obolibrary.org/obo/NCIT_C37264) (Benign Mixed Epithelial Stromal Tumor of the Kidney), [NCIT:C3618](http://purl.obolibrary.org/obo/NCIT_C3618) (Benign Bladder Neoplasm), [NCIT:C3617](http://purl.obolibrary.org/obo/NCIT_C3617) (Benign Ureter Neoplasm), [NCIT:C3616](http://purl.obolibrary.org/obo/NCIT_C3616) (Benign Renal Pelvis Neoplasm), [NCIT:C4528](http://purl.obolibrary.org/obo/NCIT_C4528) (Renal Pelvis Urothelial Papilloma), [NCIT:C3619](http://purl.obolibrary.org/obo/NCIT_C3619) (Benign Urethral Neoplasm), 

**Class expressions from DL-Learner:**

- Thing 51.96%
- [NCIT:C12922](http://purl.obolibrary.org/obo/NCIT_C12922) (Neoplastic Cell) 47.22%
- [NCIT:C12913](http://purl.obolibrary.org/obo/NCIT_C12913) (Abnormal Cell) 46.96%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40107](http://purl.obolibrary.org/obo/NCIT_C40107) (Borderline Fallopian Tube Serous Tumor/Atypical Proliferative Serous Tumor))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40104](http://purl.obolibrary.org/obo/NCIT_C40104) (Fallopian Tube Transitional Cell Carcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40103](http://purl.obolibrary.org/obo/NCIT_C40103) (Fallopian Tube Mucinous Adenocarcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40093](http://purl.obolibrary.org/obo/NCIT_C40093) (Ovarian Squamous Cell Carcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40090](http://purl.obolibrary.org/obo/NCIT_C40090) (Ovarian Seromucinous Carcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40086](http://purl.obolibrary.org/obo/NCIT_C40086) (Ovarian Clear Cell Cystadenofibroma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40083](http://purl.obolibrary.org/obo/NCIT_C40083) (Borderline Ovarian Clear Cell Cystadenofibroma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40082](http://purl.obolibrary.org/obo/NCIT_C40082) (Borderline Ovarian Clear Cell Adenofibroma with Intraepithelial Carcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C4008](http://purl.obolibrary.org/obo/NCIT_C4008) (Recurrent Gallbladder Carcinoma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40079](http://purl.obolibrary.org/obo/NCIT_C40079) (Ovarian Clear Cell Adenocarcinofibroma))) 43.69%
- [NCIT:C36778](http://purl.obolibrary.org/obo/NCIT_C36778) (Malignant Transitional Cell) and (not ([NCIT:C40075](http://purl.obolibrary.org/obo/NCIT_C40075) (Ovarian Endometrioid Cystadenoma))) 43.69%


